ArticleScientific reports2017

Targeting BMK1 Impairs the Drug Resistance to Combined Inhibition of BRAF and MEK1/2 in Melanoma.

Chengli Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.